cromakalim has been researched along with Glaucoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bahler, CK; Dosa, PI; Fautsch, MP; Holman, BH; Roy Chowdhury, U | 1 |
Dosa, PI; Fautsch, MP; Roy Chowdhury, U | 1 |
1 review(s) available for cromakalim and Glaucoma
Article | Year |
---|---|
ATP sensitive potassium channel openers: A new class of ocular hypotensive agents.
Topics: Animals; Antihypertensive Agents; Cromakalim; Diazoxide; Glaucoma; Humans; Intraocular Pressure; KATP Channels; Nicorandil; Trabecular Meshwork | 2017 |
1 other study(ies) available for cromakalim and Glaucoma
Article | Year |
---|---|
Ocular Hypotensive Effects of the ATP-Sensitive Potassium Channel Opener Cromakalim in Human and Murine Experimental Model Systems.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Animals; Cells, Cultured; Cromakalim; Drug Therapy, Combination; Eye; Female; Glaucoma; Humans; Intraocular Pressure; KATP Channels; Latanoprost; Male; Mice; Mice, Inbred C57BL; Middle Aged; Models, Biological; Prostaglandins F, Synthetic; Tissue Donors | 2015 |